You are here

News

Comment

Discuss

Coverage of the latest news and updates from the field of stem cells.

September 20, 2017

Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called “epigenetic” changes in the cells consistent with the earliest steps toward lung cancer development.

September 18, 2017

India’s Department of Biotechnology announced that it has implemented a cooperative program with Japan to accelerate the application of stem cell technology in human disease with four institutions from India participating with the Centre for iPS Cell Research and Application (CiRA), Kyoto Univers

September 18, 2017

Scientists at the Scripps Research Institute (SRI) have found a new approach to the “reprogramming” of ordinary adult cells into stem cells.

September 15, 2017

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Cellect Biotechnology Ltd.'s ApoGraft™ for the prevention of acute and chronic graft versus host disease(GvHD) in transplant patients. Cellect is a developer of stem cells selection technology.

September 13, 2017

Macular degeneration is the leading cause of vision loss in older adults, but scientists have long struggled to study and replicate key elements of the disease in the lab.

September 13, 2017

While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer. New research from Washington University School of Medicine in St.

September 11, 2017

Longeveron LLC, a regenerative medicine company developing cellular therapies, has treated its first patient in a Phase 2b clinical trial evaluating the safety and efficacy of its human allogeneic mesenchymal stem cells (LMSCs) in patients with aging frailty syndrome. Aging frailty is a comm

September 11, 2017

Scientists working to develop new treatments for neurodegenerative diseases have been stymied by the inability to grow human motor neurons in the lab.

September 8, 2017

Scientists at Children's Hospital of Philadelphia (CHOP) report that a drug candidate that blocks abnormal protein signals may lead to the first pharmacologic treatment for hereditary multiple exostoses (HME), a rare pediatric genetic disease.

September 8, 2017

The U.S. Food and Drug Administration took what it called “decisive action to prevent the use of a potentially dangerous and unproven treatment” belonging to StemImmune Inc.

Pages